Summary
The nonsteroidal anti-inflammatory compound nimesulide (4-nitro-2-phenoxymethane sulfonanilide) antagonises the effect of histamine and inhibits the release of this autacoid during immunological reaction in guinea-pigs. The antihistaminic activity of nimesulide, studied in isolated guinea-pig trachea, is specific for the H1-receptor and is of a noncompetitive type. At a concentration of 1 × 10−5 mol/L, the potency of nimesulide is nearly half that of mepyramine (pyrilamine) at 1 × 10−6 mol/L. Furthermore, unlike indomethacin, nimesulide dose-dependently antagonises the effect of histamine on airway resistance of anaesthetised guinea-pigs. In actively ovalbumin-sensitised anaesthetised guinea-pigs, both nimesulide and indomethacin significantly protected the animals from the fatal systemic anaphylactic crisis. However, in perfused sensitised guinea-pig lungs, nimesulide reduced the anaphylactic release of histamine in a concentration-dependent way, whereas indomethacin, in spite of its inhibitory potency on thromboxane A2 formation, potentiated the immune release of histamine. The bronchoconstriction induced by acetaldehyde, administered by aerosol (2.5% in saline) in sensitised anaesthetised guinea-pigs, was substantially reduced by both nimesulide and mepyramine administered by inhalation and by intravenous injection. These data further support the antihistaminic property of nimesulide and also suggest a possible interference of the compound with the degranulation process of sensitised mast cells in response to acetaldehyde. In conclusion, the capacity of nimesulide to control the immunological release of histamine and to attenuate its effect at the receptor level of the airway smooth muscles of the guinea-pig, may have some therapeutic relevance in patients with inflammation of the respiratory tract aggravated by intolerance to aspirin-like drugs.
Similar content being viewed by others
References
Adams GK, Lichtenstein LM. Indomethacin enhances response of human bronchus to antigen. American Review of Respiratory Disease 131 (Suppl. 1): 8–10, 1985
Adcock JJ, Garland LG, Moncada S, Salmon GA. The mechanisms of, enhancement by fatty acid hydroperoxides of ana-phylactic mediator release. Prostaglandins 16: 179–187, 1978
Berti F, Folco GC, Nicosia S, Omini C, Pasargiklian R. The role of histamine H1- and H2-receptors in the generation of thromboxane A2 in perfused guinea-pig lungs. British Journal of Pharmacology 65: 629–633, 1979
Berti F, Galli G, Magni F, Puglisi L, Rossoni G, et al. BN-52021, a specific PAF-receptor antagonist, prevents antigen-induced mediator release and myocardial changes in guinea-pig perfused heart. In Braquet P (Ed.) Ginkgolides, chemistry, biology, pharmacology and clinical perspectives. Vol. 1, pp. 399–410, J.R. Prous Science Publishers, SA, Barcelona, 1988
Biscarini L, Pattoia L, Del Favero A. Nimesulide a new nonsteroidal anti-inflammatory agent. Drugs of Today 24 (Suppl. 1): 23–27, 1988
Cadeddu L, Piragine F, Puxeddu P, Scornavacche V, Sellari Franceschini S. Comparison of nimesulide and flurbiprofen in the treatment of non-infectious acute inflammation of the upper respiratory tract. Journal of International Medical Research 16: 466–473, 1988
Capsoni F, Venegoni E, Minonzio F, Ongari AM, Maresca V, et al. Inhibition of neutrophil oxidative metabolism by nimesulide. Agents and Actions 21: 121–129, 1987
Chung KF. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 41 (Suppl. 9): 657–662, 1986
Davies GE, Johnston TP. Quantitative studies on anaphylaxis in guinea pigs passively sensitized with homologous antibodies. International Archives of Allergy and Applied Immunology 41: 648–654, 1971
Douglas JS, Ridgway P, Brink C. Airway responses of the guinea-pig in vivo and in vitro. Journal of Pharmacology and Experimental Therapeutics 202: 116–124, 1977
Finiguerra M, Conti P, Galione F, Ferrario F. Un nuovo antiinfiammatorio non steroideo, nimesulide, nel trattamento delle forme infiammatorie di interesse pneumologico. Clinica Terapeutica 117 (Suppl. 3): 199–206, 1986
Gilmore N, Vane JR, Wyllie TH. Prostaglandins released by the spleen. Nature 218: 1135–1140, 1968
Grant TJ, Moore GGI, Swingle KF. Antiinflammatory activity of 4-nitro-2-phenoxymethanesulfonanilide (R-805). Federation Proceedings 34: 759, 1975
Konzett H, Rössler R. Versuchsanordnung Zu Untersuchungen an der bronchial muskulatur. Archiv Für Experimentelle Pathologie und Pharmakologie 195: 71–74, 1940
Levi R. Effect of exogenous and immunologically released histamine on the isolated heart: a quantitative comparison. Journal of Pharmacology and Experimental Therapeutics 182: 227–238, 1972
Mantovani M, Dal Prá L. Nuova prospettiva terapeutica nella patologia infiammatoria delle vie aeree: Aulin. Otorinolaringologia 37: 1–7, 1987
Mills JE, Widdicombe JG. Role of the vagus nerves in anaphylaxis and histamine-induced bronchoconstrictions in guinea-pigs. British Journal of Pharmacology 39: 724–731, 1970
Milvio C. Nimesulide for the treatment of painful inflammatory process in the ear, nose and throat areas: a double-blind controlled study with benzydamine. Journal of International Medical Research 12 (Suppl. 6): 327–332, 1984
Piper PJ, Vane JR. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature 233: 29–35, 1969
Raphael GD, Metcalf DD. Mediators of airway inflammation. European Journal of Respiratory Diseases 147: 44–56, 1986
Reiner M. Nimesulide in the short-term treatment of osteoarthrosis: a pilot study for assessing the minimal effective dose. Journal of International Medical Research 10: 92, 1982
Reiner M. Nimesulide and antibiotics in the treatment of acute infections of the respiratory tract. Current Medical Research and Opinion 8 (Suppl. 7): 487–492, 1983
Rossoni G, Omini C, Viganò T, Mandelli V, Folco GC, et al. Bronchoconstriction by histamine and bradykinin in guineapigs: relationship to thromboxane A2 generation and the effect of aspirin. Prostaglandins 20: 547–557, 1980
Rufer C, Shillinger E, Böttcher I, Repenthin W, Herrmann CH. Non-steroidal anti-inflammatories-XII. Mode of action of anti-inflammatory methane sulfonanilides. Biochemical Pharmacology 31: 3591–3596, 1982
Simmons PM, Salmon JA, Moncada S. The release of leukotriene B4 during experimental inflammation. Biochemical Pharmacology 32: 1353–1359, 1983
Swingle KF, Moore GGI, Grant TJ. 4-nitro-2-phenoxymethane-sulfonanilide (R-805): a chemically novel anti-inflammatory agent. Archives Internationales de Pharmacodynamie et de Thérapie 221: 132–139, 1976
Vane JR. The use of isolated organs for detecting active substances in the circulating blood. British Journal of Pharmacology and Chemotherapy 23: 360–373, 1964
Vigdhal RL, Tukey RH. Mechanisms of action of novel anti-inflammatory drugs diflumidone and R-805. Biochemical Pharmacology 26: 307–311, 1977
Weissenbach R. Clinical trial with nimesulide, a new non steroidal anti-inflammatory agent in rheumatic pathology. Journal of International Medical Research 9: 349, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berti, F., Rossoni, G., Buschi, A. et al. Nimesulide, a Nonsteroidal Anti-Inflammatory Drug, Displays Antianaphylactic and Antihistaminic Activity in Guinea-Pigs. Drug Invest 3 (Suppl 2), 39–47 (1991). https://doi.org/10.1007/BF03258317
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03258317